Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Meir Liron is active.

Publication


Featured researches published by Meir Liron.


BMJ | 1996

Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: case control study over three years

Moshe Weintraub; Itamar Grosskopf; Toby Rassin; Hylton Miller; Gideon Charach; Heschi H. Rotmensch; Meir Liron; Ardon Rubinstein; Adrian Iaina

Abstract Objective: To test the hypothesis that subjects who clear chylomicron remnants slowly from plasma may be at higher risk of coronary artery disease than indicated by their fasting plasma lipid concentrations. Design: Case control study over three years. Setting: An 800 bed general municipal hospital. Subjects: 85 normolipidaemic patients with coronary artery disease selected prospectively and matched with 85 normolipidaemic subjects with normal coronary arteries on angiography. Interventions: All subjects were given a vitamin A fat loading test which specifically labels intestinal lipoproteins with retinyl palmitate. Main outcome measure: Postprandial lipoprotein metabolism. Results: The area below the chylomicron remnant retinyl palmitate curve was significantly increased in the coronary artery disease group as compared with the controls (mean 23.4 (SD 15.0) v 15.3 (8.9) µmol/l.h; 95% confidence interval of difference 4.37 to 11.82). Conclusions: Normolipidaemic patients with coronary artery disease had significantly higher concentrations of chylomicron remnants in plasma than normolipidaemic subjects with normal coronary vessels. This may explain the mechanism underlying the susceptibility to atherosclerosis of coronary artery disease patients with normal fasting lipid values. As diet and drugs can ameliorate the accumulation of postprandial lipoproteins in plasma, the concentration of chylomicron remnants should be measured in patients at high risk of coronary artery disease. Key messages Key messages The atherogenic effect of postprandial lipoproteins is hypothesised to be inversely related to their metabolic capacity Patients with coronary artery disease have decreased metabolic capacity of chylomicron remnants as compared with subjects with normal coronary arteries An ensuing postprandial dyslipidaemia may exist in patients with coronary artery disease who have normal fasting lipid values A vitamin A fat loading test may be useful in identifying these patients


American Heart Journal | 1980

Possible association of pneumonitis with amiodarone therapy.

Heschi H. Rotmensch; Meir Liron; Marcel Tupilski; Shlomo Laniado


Kidney International | 1992

Severe defect in clearing postprandial chylomicron remnants in dialysis patients

Moshe Weintraub; Amira Burstein; Toby Rassin; Meir Liron; Yehuda Ringel; Shaltiel Cabili; Miriam Blum; Gary Peer; Adrian Iaina


JAMA Internal Medicine | 1984

Histiocytic Hemophagocytosis in Miliary Tuberculosis

Moshe Weintraub; Yardena Siegman-Igra; Josef Josiphov; Rodika Rahmani; Meir Liron


Journal of Lipid Research | 1994

Continuous intravenous heparin administration in humans causes a decrease in serum lipolytic activity and accumulation of chylomicrons in circulation.

Moshe Weintraub; Toby Rassin; S Eisenberg; Yehuda Ringel; Itamar Grosskopf; A Iaina; Gideon Charach; Meir Liron; Ardon Rubinstein


Annals of Internal Medicine | 1978

Granulomatous Hepatitis: A Hypersensitivity Response to Procainamide

Heschi H. Rotmensch; Israel Yust; Yardena Siegman-Igra; Meir Liron; Bianca Ilie; Nurith Vardinon


JAMA Internal Medicine | 1981

Evaluation of prajmalium-induced cholestasis by immunologic tests.

Heschi H. Rotmensch; Alfredo Leiser; Michael Dan; Avraham Klejman; Ella Livni; B. Ilie; Glenda Messer; Uri Kadish; Meir Liron


BMJ | 1980

Lymphocyte sensitisation in nifedipine-induced hepatitis.

Heschi H. Rotmensch; A Roth; Meir Liron; Ardon Rubinstein; A Gefel; E Livni


The Journals of Gerontology | 1992

Octogenarian Subjects Have Low Postprandial Levels of Chylomicron Remnants: A Possible Explanation for Protection Against Atherosclerosis

Moshe Weintraub; Yehuda Ringel; Toby Rassin; Jacob Arad; Gershon Bodner; Meir Liron


JAMA Internal Medicine | 1982

Massive Reversible Prerenal Azotemia

Heschi H. Rotmensch; Gershon Bodner; Meir Liron

Collaboration


Dive into the Meir Liron's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Moshe Weintraub

Tel Aviv Sourasky Medical Center

View shared research outputs
Top Co-Authors

Avatar

Toby Rassin

Tel Aviv Sourasky Medical Center

View shared research outputs
Top Co-Authors

Avatar

Ardon Rubinstein

Tel Aviv Sourasky Medical Center

View shared research outputs
Top Co-Authors

Avatar

Gershon Bodner

Tel Aviv Sourasky Medical Center

View shared research outputs
Top Co-Authors

Avatar

Yehuda Ringel

Tel Aviv Sourasky Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gideon Charach

Tel Aviv Sourasky Medical Center

View shared research outputs
Top Co-Authors

Avatar

Itamar Grosskopf

Tel Aviv Sourasky Medical Center

View shared research outputs
Top Co-Authors

Avatar

A Iaina

Tel Aviv Sourasky Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge